Cambridge Investment Research Advisors’s Trustmark TRMK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.2M Sell
26,167
-738
-3% -$32.9K ﹤0.01% 2134
2026
Q1
$1.13M Sell
26,905
-124
-0.5% -$5.23K ﹤0.01% 2059
2025
Q4
$1.05M Sell
27,029
-292
-1% -$11.4K ﹤0.01% 2052
2025
Q3
$1.08M Buy
27,321
+2
+0% +$78 ﹤0.01% 1994
2025
Q2
$996K Buy
27,319
+4
+0% +$137 ﹤0.01% 1947
2025
Q1
$942K Buy
27,315
+1,080
+4% +$38.5K ﹤0.01% 1920
2024
Q4
$928K Buy
26,235
+59
+0.2% +$2.13K ﹤0.01% 1932
2024
Q3
$833K Buy
26,176
+19,253
+278% +$619K ﹤0.01% 1996
2024
Q2
$208K Buy
+6,923
New +$199K ﹤0.01% 2999
2024
Q1
Sell
-9,553
Closed -$266K 3396
2023
Q4
$266K Buy
+9,553
New +$221K ﹤0.01% 2684
2016
Q3
Sell
-28,831
Closed -$716K 1786
2016
Q2
$716K Buy
28,831
+14
+0% +$337 0.02% 768
2016
Q1
$664K Sell
28,817
-622
-2% -$13.7K 0.02% 753
2015
Q4
$678K Buy
+29,439
New +$713K 0.02% 715

Other funds holding TRMK

Cambridge Investment Research Advisors's TRMK Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its Trustmark (TRMK) stake by 2.7% in Q2 2026, selling an estimated $32.9K and leaving 26,167 shares worth $1.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2134.

Cambridge Investment Research Advisors first reported a position in TRMK in Q4 2015 and has held it in 13 quarters since. 289 funds tracked by Wall St. Rank hold TRMK as of Q2 2026.

  • Cambridge Investment Research Advisors held 26,167 shares of Trustmark worth $1.2M as of Q2 2026.
  • Cambridge Investment Research Advisors sold 738 Trustmark shares in Q2 2026, an estimated $32.9K.
  • Trustmark made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #2134 holding.
  • Cambridge Investment Research Advisors first reported a position in Trustmark in Q4 2015 and has held it in 13 quarters since.
  • 289 funds tracked by Wall St. Rank held Trustmark as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.